Lyphochek whole blood metals control - quality control reagents

Ended Purchase Order Awarded Last action

Contract number
W81K0024P0242
Awardee
Awarding agency
Obligated
$546,292

Award facts

Contract value 39% obligated
  • $820,639.67 Current, with exercised options
  • $1,385,905.70 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Exercise an Option P00006 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-24-P-0242 with biorad laboratories, INC., is hereby… $0
Supplemental Agreement for work within scope P00005 · Federal acquisition regulation (far) 52.232-18, availability of funds, FY26 funds are available and hereby obligated for W81K00-24-P-0242 and remove sub-clins… $268,968
Exercise an Option P00004 · Pursuant to federal acquisition regulation (far) 52.217-9, option to extend the term of the contract, W81K00-24-P-0242 with biorad laboratories, INC., is hereby… $0
Supplemental Agreement for work within scope P00003 · Increase quantity and add new reagents. $136,357
Supplemental Agreement for work within scope P00002 · Decrease quantities of reagents. -$138,071
Funding Only Action P00001 · Lyphochek whole blood metals control LEV - FY25 funding modification $279,038
Original award $0

About this award

Defense Health Agency awarded a firm-fixed-price purchase order to Bio Rad Laboratories Inc. on October 1, 2024, with a ceiling value of $1,385,905.70, for Lyphochek Whole Blood Metals Control quality control reagents. The order carries no set-aside, and the awardee is a large business competing full-and-open. Place of performance is Fort Sam Houston, Texas. Under FAR 52.217-9, the government exercised Option Year 2, extending the term for 01 October 2026 through 30 September 2027, with ultimate completion on September 30, 2029. The originating pre-solicitation was posted April 1, 2024 by the Army Medical Command's Medical Readiness Contracting Office - West, with responses due April 15, 2024. It sought clinical chemistry and immunochemistry QC products for Brooke Army Medical Center, Texas, under a 12-month base period with four 12-month options.

Quick answers

Who was awarded contract W81K0024P0242?

W81K0024P0242 was awarded to Bio Rad Laboratories Inc. by Medical Command (Department of the Army) on October 1, 2024.

How much is contract W81K0024P0242 worth?

The government has obligated $546,292 on W81K0024P0242. Its current value, with exercised options, is $820,640. Its potential value, with all options, is $1,385,906.

Which agency awarded contract W81K0024P0242?

Medical Command (Department of the Army) awarded W81K0024P0242, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0024P0242 competed?

The extent of competition for W81K0024P0242 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award